Lab Automation Market Set for Robust Growth to US$ 8.97 Billion by 2030, Led by North America's 51.6% Market Share | Key Players - Thermo Fisher Scientific, Tecan Group, Siemens Healthineers

The Lab Automation Market reached US$ 5.93 billion in 2024 and is expected to reach US$ 8.97 billion by 2030, growing at a robust CAGR of 7.1% during the forecast period 2025-2030.

Market growth is driven by increasing demand for high-throughput screening, rising adoption of automated systems in drug discovery and diagnostics, and the need to minimize human intervention for more accurate results. Advancements in robotics and AI integration, expanding pharmaceutical R&D pipelines, growing investments in lab efficiency, and increased focus on precision diagnostics are further accelerating market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/lab-automation-market?ram

Key Industry Developments

United States:
✅ January 2026: Thermo Fisher Scientific launched the next-generation KingFisher Flex Purification System with enhanced AI-driven sample processing capabilities, significantly improving throughput for high-volume genomics labs and reducing hands-on time by 40% through automated magnetic bead workflows.
​
✅ December 2025: Agilent Technologies unveiled the BioTek Multi-Mode Microplate Reader series upgrade featuring integrated robotics for seamless assay automation, enabling real-time data analysis and supporting precision medicine R&D with adaptive optics technology.
​
✅ November 2025: Beckman Coulter Life Sciences introduced the Biomek i-Series automated liquid handler with modular AI enhancements, optimizing piptting precision for drug discovery pipelines and integrating with LIMS for end-to-end traceability in US biopharma facilities.
​
Asia Pacific / Japan:
✅ January 2026: Hitachi High-Tech launched the advanced UKON-EX automated pretreatment system for mass spectrometry, incorporating robotic arms and AI algorithms to boost proteomic analysis efficiency in Japanese research institutes.
​
✅ December 2025: Shimadzu Corporation released the Nexera XR ultra-high-performance liquid chromatography system with full robotic automation, streamlining metabolomics workflows and enhancing reproducibility for Japan's precision medicine initiatives.
​
✅ October 2025: Daiichi Sankyo opened a cutting-edge automation-equipped research facility in collaboration with robotics partners, deploying dual-armed robots for cell culture and high-throughput screening to accelerate oncology drug development.

Strategic Mergers and Acquisitions:
✅ ABB Robotics and Agilent Technologies formed a key strategic collaboration on January 24, 2025, integrating ABB's robotic technology with Agilent's analytical instruments to advance next-generation lab automation systems for pharmaceuticals and biotech.
​
Key Players:
Thermo Fisher Scientific | Tecan Group | Siemens Healthineers | Roche Holding AG | QIAGEN N.V. | PerkinElmer Inc. | Hamilton Robotics Inc. | Agilent Technologies | Beckman Coulter Inc.

Strategic Leadership Report: Top 5 Players in Lab Automation Market 2026
-Thermo Fisher Scientific: Deployed the Thermo Scientific AquaMax 4000 Microplate Washer with enhanced automation for high-throughput screening, streamlining liquid handling and reducing cross-contamination in drug discovery workflows.

-Tecan Group: Launched the Tecan Resolve i1300 workstation, integrating AI-driven piptting and modular robotics to accelerate personalized medicine research and biomarker analysis with precise, scalable automation.

-Siemens Healthineers: Advanced Atellica Integrated Automation, consolidating 25 manual tasks into a scalable trackless system that cuts lab workload by up to 75% while enabling faster turnaround times for diverse testing volumes.

-Roche Holding AG: Introduced the cobas pro integrated solutions platform, featuring fully automated sample management and analyzer connectivity to boost diagnostic efficiency and support high-volume clinical labs with minimal errors.

-Agilent Technologies: Released the Agilent Bravo automated liquid handling platform with updated AssayMAP V accessories, optimizing sample prep for proteomics and genomics to deliver reproducible results in automated research pipelines.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=lab-automation-market?ram

Market Drivers and Key Trends:
-High-Throughput Demand: Lab automation accelerates drug discovery and genomics research by enabling rapid screening and processing of large sample volumes, reducing turnaround times in pharmaceutical and biotech labs.

-Error Reduction: Automation minimizes human errors in repetitive tasks like piptting and data handling, improving accuracy, reproducibility, and compliance in clinical diagnostics and quality control.

-Cost Efficiency: By streamlining workflows and cutting manual labor needs, lab automation lowers operational costs amid rising R&D investments and personnel shortages, especially in North America and Asia-Pacific.

-AI Integration: Advancements in robotics, AI-driven analytics, and modular systems boost data insights and predictive capabilities, fueling adoption in personalized medicine and high-complexity testing.

-Market Hurdles: High initial setup costs, integration challenges with legacy systems, and skilled personnel shortages for maintenance limit widespread adoption, particularly in emerging regions.

Regional Insights:
-North America: 51.6%
Largest share, led by advanced healthcare infrastructure, a dense cluster of pharmaceutical and biotech companies, and high‐throughput‐screening‐driven demand for automation in research and diagnostics.​

-Asia Pacific: 21.8%
Second‐largest region and fastest‐growing, driven by expanding pharmaceutical manufacturing, rising lab capacity in China, India, and Japan, and increasing government/private‐sector backing for lab‐automation projects.

-Europe: 17.2%
Third‐largest region, supported by mature life‐sciences ecosystems, digital‐diagnostics reforms, and strong regulatory emphasis on precision, reproducibility, and data integrity in clinical and research labs.

-Latin America: 5.1%
Growing incrementally, as hospitals and central labs in Brazil, Mexico, and selected Andean countries adopt modular automation to manage higher test volumes and staff‐shortage‐related bottlenecks.

-Middle East & Africa: 4.3%
Smaller but structurally growing segment, where urban‐center hospitals and reference labs in GCC and South Africa are investing in total‐lab‐automation and integrated systems for accreditation and turnaround‐time targets.

Market Opportunities & Challenges: Lab Automation Market 2026
-Opportunities: A "Smart Lab Integration" wave accelerates adoption, with AI-driven robotics and cloud platforms enabling seamless workflows for genomics and precision medicine. Regulatory pushes for faster drug discovery, alongside pharma-biotech partnerships, unlock scalable entry for modular automation providers targeting high-throughput screening.

-Challenges: Legacy infrastructure integration hurdles inflate retrofit costs, while a skilled technician shortage demands intensive upskilling amid rising cybersecurity vulnerabilities in connected systems. Success hinges on overcoming vendor lock-in across fragmented robotics ecosystems.

-Strategic Verdict: AI-enhanced modular systems and genomics-focused automation emerge as core growth drivers for 2026.​

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lab-automation-market?ram

Market Segmentation Analysis:
-By Product Type: Automated Liquid Handling Systems Lead Efficiency Gains
Automated liquid handling systems dominate with 42% market share in 2025, enabling high-throughput piptting for precise, error-free workflows in labs.
Microplate readers follow at 25%, vital for rapid absorbance/fluorescence assays in screening.
Automated storage and retrieval systems claim 18%, optimizing sample inventory via robotics.
Others, like robotic arms, hold 15% for specialized automation.

-By Application: Drug Discovery Tops R&D Demand
Drug discovery leads at 35% share, accelerating hit identification and compound testing.
Clinical diagnostics secure 28%, streamlining high-volume pathogen and biomarker analysis.
Genomics solutions take 22%, powering sequencing and PCR automation.
Clinical discovery accounts for 15% in trial sample processing.

-By End-User: Pharma and Biotech Companies Command Largest Share
Pharma and biotech firms hold 55% share, investing heavily in scaling R&D pipelines.
Diagnostic laboratories follow at 45%, adopting automation for faster, accurate testing volumes.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.